Form D · Pharmaceuticals

Invirsa, Inc.

Columbus, OH · CIK 0001836108

Offering snapshot reported Aug 8, 2025 · SEC filing

Reported sold
$2.86M
Offering amount: $2.86M
Investors reported
14
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Jul 22, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 8, 2025Amendment$2,860,000No comparison14SEC filing
Aug 6, 2025Initial$2,832,000No comparison14SEC filing
Nov 29, 2023Initial$999,998No comparison1SEC filing
Dec 29, 2022Initial$5,976,217No comparison8SEC filing
Dec 11, 2020Initial$40,245No comparison1SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-553807

Source: Form D, filed Aug 8, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wayne Embree Director
Bethany George Director
Samuel Lee Director
Robert Shalwitz Director, Executive
Michael Venerable Director
Faith Voinovich Director
Tim Willis Director
Rachael Wingo Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1275 Kinnear Road
Columbus, OH, 43212
Phone: 614-715-1860